Outcome of pulmonary rehabilitation in COPD patients with severely impaired health status

International Journal of COPD

Volumn 6, Issue 1, 2011, Pages 647-657

  van Ranst, Dirk ^a   Otten, Henk ^a,b   Meijer, Jan Willem ^a   van't Hul, A J ^a,c  

^a Revant Pulmonary Rehabilitation Center 'schoondonck'   (Netherlands)

^b ERASMUS MEDICAL CENTER   (Netherlands)

^c VU UNIVERSITY AMSTERDAM   (Netherlands)

Author keywords

6MWDT; BODE index; HRQL; Pulmonary rehabilitation; SGRQ

Indexed keywords

ADULT; ARTICLE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; HEALTH CARE UTILIZATION; HEALTH PROGRAM; HEALTH STATUS; HUMAN; MAJOR CLINICAL STUDY; MALE; OBSERVATIONAL STUDY; OUTCOME ASSESSMENT; PHYSICAL ACTIVITY; PREDICTION; PULMONARY REHABILITATION; QUALITY OF LIFE; RETROSPECTIVE STUDY; SYNDROME DELINEATION; THERAPY EFFECT; TOTAL QUALITY MANAGEMENT; WALKING; CHI SQUARE DISTRIBUTION; EXERCISE TEST; HOSPITALIZATION; MIDDLE AGED; NETHERLANDS; PATHOPHYSIOLOGY; QUESTIONNAIRE; REGRESSION ANALYSIS; STATISTICAL MODEL; TREATMENT OUTCOME;

CHI-SQUARE DISTRIBUTION; EXERCISE TEST; FEMALE; HUMANS; LOGISTIC MODELS; MALE; MIDDLE AGED; NETHERLANDS; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; QUALITY OF LIFE; QUESTIONNAIRES; REGRESSION ANALYSIS; RETROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME;

EID: 84859221791     PISSN: 11769106     EISSN: 11782005     Source Type: Journal    
DOI: 10.2147/copd.s24579     Document Type: Article

References (47)

1. Lahaije AJ, van Helvoort HA, Dekhuijzen PN, Heijdra YF. Physiologic limitations during daily life activities in COPD patients. Respir Med. 2010;104(8):1152-1159.
2. Reardon JZ, Lareau SC, Zuwallack R. Functional status and quality of life in chronic obstructive pulmonary disease. Am J Med. 2006;119 (10 Suppl 1):32-37.
3. Man WD, Kemp P, Moxham J, Polkey MI. Exercise and muscle dysfunction in COPD: implications for pulmonary rehabilitation. Clin Sci (Lond). 2009;117(8):281-291.
4. Lacasse Y, Goldstein R, Lasserson TJ, Martin S. Pulmonary rehabilitation for chronic obstructive pulmonary disease. Cochrane Database Syst Rev. 2006;(4):CD003793.
5. Langer D, Hendriks E, Burtin C, et al. A clinical practice guideline for physiotherapists treating patients with chronic obstructive pulmonary disease based on a systematic review of available evidence. Clin Rehabil. 2009;23(5):445-462.
6. Nici L, Donner C, Wouters E, et al. American Thoracic Society/ European Respiratory Society statement on pulmonary rehabilitation. Am J Respir Crit Care Med. 2006;173(12):1390-1413.
7. Ries AL, Bauldoff GS, Carlin B W, et al. Pulmonary Rehabilitation: Joint ACCP/AACVPR Evidence-Based Clinical Practice Guidelines. Chest. 2007;131(Suppl 5):4S-42S.
8. Peters JB, Daudey L, Heijdra Y F, Molema J, Dekhuijzen PN, Vercoulen JH. Development of a battery of instruments for detailed measurement of health status in patients with COPD in routine care: the Nijmegen Clinical Screening Instrument. Qual Life Res. 2009;18(7):901-912.
9. Rothwell PM. External validity of randomised controlled trials: "to whom do the results of this trial apply?" Lancet. 2005;365(9453):82-93.
10. Bjoernshave B, Korsgaard J, Nielsen C V. Does pulmonary rehabilitation work in clinical practice? A review on selection and dropout in randomized controlled trials on pulmonary rehabilitation. Clin Epidemiol. 2010;2: 73-83.
11. Vercoulen JH, Daudey L, Molema J, et al. An Integral assessment framework of health status in chronic obstructive pulmonary disease (COPD). Int J Behav Med. 2008;15(4):263-279.
12. Stucki A, Stoll T, Cieza A, et al. ICF Core Sets for obstructive pulmonary diseases. J Rehabil Med. 2004;(Suppl 44):114-120.
13. Glaab T, Vogelmeier C, Buhl R. Outcome measures in chronic obstructive pulmonary disease (COPD): strengths and limitations. Respir Res. 2010;11:79.
14. Miller MR, Hankinson J, Brusasco V, et al. Standardisation of spirometry. Eur Respir J. 2005;26(2):319-338.
15. Wanger J, Clausen JL, Coates A, et al. Standardisation of the measurement of lung volumes. Eur Respir J. 2005;26(3):511-522.
16. MacIntyre N, Crapo RO, Viegi G, et al. Standardisation of the single-breath determination of carbon monoxide uptake in the lung. Eur Respir J. 2005;26(4):720-735.
17. Quanjer PH, Tammeling GJ, Cotes JE, Pedersen O F, Peslin R, Yernault JC. Lung volumes and forced ventilatory fows. Report Working Party Standardization of Lung Function Tests, European Community for Steel and Coal. Offcial Statement of the European Respiratory Society. Eur Respir J Suppl. 1993;16:5-40.
18. Palange P, Ward SA, Carlsen KH, et al. Recommendations on the use of exercise testing in clinical practice. Eur Respir J. 2007;29(1): 185-209.
19. Bestall JC, Paul EA, Garrod R, et al. Usefulness of the Medical Research Council (MRC) dyspnoea scale as a measure of disability in patients with chronic obstructive pulmonary disease. Thorax. 1999;54:581-586.
20. Celli BR, Cote CG, Marin JM, et al. The body-mass index, airfow obstruction, dyspnea, and exercise capacity index in chronic obstructive pulmonary disease. N Engl J Med. 2004;350(10):1005-1012.
21. Andrews AW, Thomas MW, Bohannon RW. Normative values for isometric muscle force measurements obtained with hand-held dynamometers. Phys Ther. 1996;76(3):248-259.
22. ATS/ERS Statement on respiratory muscle testing. Am J Respir Crit Care Med. 2002;166(4):518-624.
23. Black LF, Hyatt RE. Maximal respiratory pressures: normal values and relationship to age and sex. Am Rev Respir Dis. 1969;99(5): 696-702.
24. O'Donnell DE, Travers J, Webb KA, et al. Reliability of ventilatory parameters during cycle ergometry in multicentre trials in COPD. Eur Respir J. 2009;34(4):866-874.
25. Laviolette L, Bourbeau J, Bernard S, et al. Assessing the impact of pulmonary rehabilitation on functional status in COPD. Thorax. 2008; 63(2):115-121.
26. ATS Committee on Profciency Standards for Clinical Pulmonary Function Laboratories. ATS statement: guidelines for the six-minute walk test. Am J Respir Crit Care Med. 2002;166(1):111-117.
27. Troosters T, Gosselink R, Decramer M. Six minute walking distance in healthy elderly subjects. Eur Respir J. 1999;14(2):270-274.
28. Puhan MA, Chandra D, Mosenifar Z, et al. National Emphysema Treatment Trial (NETT) Research Group. The minimal important difference of exercise tests in severe COPD. Eur Respir J. 2011; 37(4):784-790. Epub August 6, 2010.
29. Guyatt GH, Berman LB, Townsend M, Pugsley SO, Chambers, LW. A measure of quality of life for clinical trials in chronic lung disease. Thorax. 1987;42(10):773-778.
30. Jaeschke R, Singer J, Guyatt GH. Measurement of health status. Ascertaining the minimal clinically important difference. Controlled Clinical Trials. 1989;10(4):407-415.
31. Jones P W, Quirk FH, Baveystock CM, Littlejohns P. A self-complete measure of health status for chronic airflow limitation. The St George's Respiratory Questionnaire. Am Rev Respir Dis. 1992;145(6): 1321-1327.
32. Jones P W. Interpreting thresholds for a clinically significant change in health status in asthma and COPD. Eur Respir J. 2002;19(3): 398-404.
33. Ware JE, Kosinski M, Keller ASD. SF-36 Physical and Mental Health Summary Scales: A user's Manual; 1994.
34. Mahler DA, Mackowiak JI. Evaluation of the short-form 36-item questionnaire to measure health-related quality of life in patients with COPD. Chest. 1995;107(6):1585-1589.
35. Wyrwich KW, Tierney WM, Babu AN, Kroenke K, Wolinsky FD. A comparison of clinically important differences in health-related quality of life for patients with chronic lung disease, asthma, or heart disease. Health Serv Res. 2005;40(2):577-591.
36. Bjorner JB, Wallenstein G V, Martin MC, et al. Interpreting score differences in the SF-36 Vitality scale: using clinical conditions and functional outcomes to defne the minimally important difference. Curr Med Res Opin. 2007;23(4):731-739.
37. Seemungal TA, Donaldson GC, Paul EA, Bestall JC, Jeffries DJ, Wedzicha JA. Effect of exacerbation on quality of life in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 1998;157(5 Pt 1):1418-1422.
38. Duiverman ML, Wempe JB, Bladder G, et al. Two-year home-based nocturnal noninvasive ventilation added to rehabilitation in chronic obstructive pulmonary disease patients: a randomized controlled trial. Respir Res. 2011;12(1):112.
39. Yohannes AM, Connolly MJ. Pulmonary rehabilitation programmes in the UK: a national representative survey. Clin Rehabil. 2004;18(4): 444-449.
40. Garrod R, Marshall J, Barley E, Jones P W. Predictors of success and failure in pulmonary rehabilitation. Eur Respir J. 2006;27(4): 788-794.
41. Schunemann HJ, Griffth L, Jaeschke R, Goldstein R, Stubbing D, Guyatt GH. Evaluation of the minimal important difference for the feeling thermometer and the St George's Respiratory Questionnaire in patients with chronic airfow obstruction. J Clin Epidemiol. 2003; 56(12):1170-1176.
42. Kuzma AM, Meli Y, Meldrum C, et al. Multidisciplinary care of the patient with chronic obstructive pulmonary disease. Proc Am Thorac Soc. 2008;5(4):567-571.
43. Han MK, Agusti A, Calverley PM, et al. Chronic obstructive pulmonary disease phenotypes: the future of COPD. Am J Respir Crit Care Med. 2010;182(5):598-604.
44. Huijsmans RJ, de Haan A, ten Hacken NN, Straver RV, van't Hul AJ. The clinical utility of the GOLD classifcation of COPD disease severity in pulmonary rehabilitation. Respir Med. 2008;102(1):162-171.
45. British Thoracic Society Standards of Care Subcommittee on Pulmonary Rehabilitation. Pulmonary rehabilitation. Thorax. 2001;56(11): 827-834.
46. Cote CG, Dordelly LJ, Celli BR. Impact of COPD exacerbations on patient-centered outcomes. Chest. 2007;131(3):696-704.
47. Crisafulli E, Gorgone P, Vagaggini B, et al. Effcacy of standard rehabilitation in COPD outpatients with comorbidities. Eur Respir J. 2010;36(5):1042-1048.